How do you approach continuation of benzodiazepines in elderly patients with anxiety who have had poor response to other medications?

This is a risk/benefit analysis question, and will be unique for each patient. The biggest danger is making an internal rule that ignores the patient's needs. Many variables come into play: if the person has been on them for years or decades, then it probably causes more harm to discontinue, as they...